Sexually Active Younger Women Are At Higher Risk For Infection With Human Papillomavirus

February 11, 1998

Sexually active college-age women have a high incidence of human papillomavirus (HPV) infection according to a study supported by the National Institute of Allergy and Infectious Disease (NIAID) and reported in the Feb. 12, 1998 issue of The New England Journal of Medicine.

"Genital infection with HPV is one of the most common sexually transmitted diseases, with its prevalence in young women ranging from 20 percent to 46 percent in different countries," says Study Director Robert D. Burk, M.D., of the Department of Pediatrics, Microbiology and Immunology, and the Department of Epidemiology and Social Medicine at the Albert Einstein College of Medicine. "The public health impact of this infection is compounded by the recognized causal relationship between genital infections with certain types of HPV and cell abnormalities of the cervix and cervical cancer."

"The incidence of HPV infection in sexually active young college women is alarming. Furthermore, we currently have no effective way to prevent infection. The need for topical microbicides and effective vaccines is urgent," says Penny Hitchcock, D.V.M., chief of the sexually transmitted diseases branch in NIAID's Division of Microbiology and Infectious Diseases. "It is certainly reassuring that only a small number of women will develop cervical cell changes or cancer. However, until we have more precise diagnostic tests, it is important for young women to have regular Pap smears."

Through campus-wide advertisements at a state university in New Brunswick, N.J., the study team enrolled 608 young women. Their average age was 20 years, and the ethnic distribution was 57 percent white, 13 percent Hispanic, 12 percent black and 18 percent other. Twenty-six percent were diagnosed with HPV infection at the beginning of the study. Each of the women had pelvic examinations and Pap smears at the study outset and annually. For a maximum of three years, the women responded at six-month intervals to questionnaires on lifestyle and sexual behavior. At the same visits, samples of cells from the cervix and vagina were taken to ascertain whether or not HPV was present and to determine the type, or strain, of HPV. If the same type of HPV was present during two consecutive visits, the infection was defined as persistent. The average duration of HPV infection was eight months.

The cumulative incidence of HPV infection in the women who were HPV-negative at baseline was 43 percent. The investigators noted, however, that this incidence decreased with time: it was 20 percent in the first 12 months; 14 percent in the second 12 months; and only 9 percent in the final 12 months.

"The encouraging news," says Dr. Hitchcock, "is that this study suggests that the body's response to infection plays an important role in limiting persistence of the virus and disease progression. If this is mediated by the immune response, it could indicate that development of prophylactic and therapeutic vaccines would play an important role in prevention and control."

Higher risk and incidence of HPV infection are associated with younger age, ethnic minority subgroups, increased frequency of alcohol consumption, anal sex or a high frequency of vaginal sex. A woman was less likely to have an HPV infection last for six months if it had been her first infection. The longer an infection endured from previous visits, the more likely it was to persist.

One of the consequences of HPV infection is the presence of various types of abnormal cells. One such type, squamous intraepithelial lesion, a potentially pre-cancerous condition, is caused by HPV infection of cervical cells, and is usually first detected as an abnormal Pap smear.

The authors caution that because of the six-month interval between medical visits, the study results may underestimate the incidence and overestimate the duration of HPV infection. They also warn that it is uncertain whether these data apply to older women.

In addition to Dr. Burk, collaborators included Gloria Y. F. Yo, Ph.D., and Chee J. Chang, Ph.D., both of the Albert Einstein College of Medicine, Bronx, N.Y.; and Robert Bierman, M.D., and Leah Beardsley, N.P., both of Rutgers University Student Health Service, New Brunswick, N.J.

NIAID, part of the National Institutes of Health (NIH), supports biomedical research to prevent, diagnose and treat illnesses such as AIDS, tuberculosis, malaria, asthma and allergies. NIH is an agency of the U.S. Department of Health and Human Services.

Press releases, fact sheets and other NIAID-related materials are available via the NIAID Web site at http://www.niaid.nih.gov.
-end-


NIH/National Institute of Allergy and Infectious Diseases

Related Infectious Diseases Articles from Brightsurf:

Understanding the spread of infectious diseases
Physicists at M√ľnster University (Germany) have shown in model simulations that the COVID-19 infection rates decrease significantly through social distancing.

Forecasting elections with a model of infectious diseases
Election forecasting is an innately challenging endeavor, with results that can be difficult to interpret and may leave many questions unanswered after close races unfold.

COVID-19 a reminder of the challenge of emerging infectious diseases
The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC).

Certain antidepressants could provide treatment for multiple infectious diseases
Some antidepressants could potentially be used to treat a wide range of diseases caused by bacteria living within cells, according to work by researchers in the Virginia Commonwealth University School of Medicine and collaborators at other institutions.

Opioid epidemic is increasing rates of some infectious diseases
The US faces a public health crisis as the opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections.

Infectious diseases could be diagnosed with smartphones in sub-Saharan Africa
A new Imperial-led review has outlined how health workers could use existing phones to predict and curb the spread of infectious diseases.

The Lancet Infectious Diseases: Experts warn of a surge in vector-borne diseases as humanitarian crisis in Venezuela worsens
The ongoing humanitarian crisis in Venezuela is accelerating the re-emergence of vector-borne diseases such as malaria, Chagas disease, dengue, and Zika virus, and threatens to jeopardize public health gains in the country over the past two decades, warn leading public health experts.

Glow-in-the-dark paper as a rapid test for infectious diseases
Researchers from Eindhoven University of Technology (The Netherlands) and Keio University (Japan) present a practicable and reliable way to test for infectious diseases.

Math shows how human behavior spreads infectious diseases
Mathematics can help public health workers better understand and influence human behaviors that lead to the spread of infectious disease, according to a study from the University of Waterloo.

Many Americans say infectious and emerging diseases in other countries will threaten the US
An overwhelming majority of Americans (95%) think infectious and emerging diseases facing other countries will pose a 'major' or 'minor' threat to the U.S. in the next few years, but more than half (61%) say they are confident the federal government can prevent a major infectious disease outbreak in the US, according to a new national public opinion survey commissioned by Research!America and the American Society for Microbiology.

Read More: Infectious Diseases News and Infectious Diseases Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.